English | 繁體

Search in the results

UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa Journal article
Zhang, L., Chen, C., Fu, J., Lilley, B., Berlinicke, C., Hansen, B., Ding, D., Wang, G., Wang, T., Shou, D., Ye, Y., Mulligan, T., Emmerich, K., Saxena, M. T., Hall, K. R., Sharrock, A. V., Brandon, C., Park, H., Kam, T. I., Dawson, V. L., Dawson, T. M., Shim, J. S., Hanes, J., Ji, H., Liu, J. O., Qian, J., Ackerley, D. F., Rohrer, B., Zack, D. J., Mumm, J. S.. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa[J]. Elife, 2021, 10.
Authors:  Zhang, L.;  Chen, C.;  Fu, J.;  Lilley, B.;  Berlinicke, C.; et al.
Favorite | TC[WOS]:12 TC[Scopus]:14  IF:6.4/7.2 | Submit date：2022/08/31
Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa Journal article
Zhang, Liyun, Chen, Conan, Fu, Jie, Lilley, Brendan, Berlinicke, Cynthia, Hansen, Baranda, Ding, Ding, Wang, Guohua, Wang, Tao, Shou, Daniel, Ye, Ying, Mulligan, Timothy, Emmerich, Kevin, Saxena, Meera T., Hall, Kelsi R., Sharrock, Abigail V., Brandon, Carlene, Park, Hyejin, Kam, Tae In, Dawson, Valina L., Dawson, Ted M., Shim, Joong Sup, Hanes, Justin, Ji, Hongkai, Liu, Jun O., Qian, Jiang, Ackerley, David F., Rohrer, Baerbel, Zack, Donald J., Mumm, Jeff S.. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa[J]. eLife, 2021, 10.
Authors:  Zhang, Liyun;  Chen, Conan;  Fu, Jie;  Lilley, Brendan;  Berlinicke, Cynthia; et al.
Favorite | TC[WOS]:12 TC[Scopus]:14  IF:6.4/7.2 | Submit date：2021/12/08
Selective targeting of BRCA1 deficient breast cancer by bromodomain and extra-terminal motif (BET) inhibitors Conference paper
Zhang, B., Yang, E. J., Lyu, J., Liu, Y., Wu, C., Chen, Q., Tan, K., Wong, K. H., Xu, X., Deng, C., Shim, J. S.. Selective targeting of BRCA1 deficient breast cancer by bromodomain and extra-terminal motif (BET) inhibitors[C], 2017.
Authors:  Zhang, B.;  Yang, E. J.;  Lyu, J.;  Liu, Y.;  Wu, C.; et al.
Favorite |  | Submit date：2022/07/27
Bromodomain and extra-terminal motif  BRCA1  synthetic lethality  
Synthetic lethality by targeting Aurora A activity in ARID1A-deficient colorectal cancer cells Conference paper
Wu, C., Yang, E. J., Lyu, J., Liu, Y., Zhang, B., Tan, K., Wong, K. H., Shim, J. S.. Synthetic lethality by targeting Aurora A activity in ARID1A-deficient colorectal cancer cells[C], 2017.
Authors:  Wu, C.;  Yang, E. J.;  Lyu, J.;  Liu, Y.;  Zhang, B.; et al.
Favorite |  | Submit date：2022/07/27
ARID1A  tumor suppressor  synthetic lethality  aurora kinase A  
Personalized chemotherapy profiling using cancer cell lines from selectable mice Journal article
Kamiyama H., Rauenzahn S., Shim J.S., Karikari C.A., Feldmann G., Hua L., Kamiyama M., Schuler F.W., Lin M.-T., Beaty R.M., Karanam B., Liang H., Mullendore M.E., Mo G., Hidalgo M., Jaffee E., Hruban R.H., Jinnah H.A., Roden R.B.S., Jimeno A., Liu J.O., Maitra A., Eshleman J.R.. Personalized chemotherapy profiling using cancer cell lines from selectable mice[J]. Clinical Cancer Research, 2013, 19(5), 1139-1146.
Authors:  Kamiyama H.;  Rauenzahn S.;  Shim J.S.;  Karikari C.A.;  Feldmann G.; et al.
Favorite | TC[WOS]:22 TC[Scopus]:23 | Submit date：2019/01/15
Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation Journal article
Rovira M., Huang W., Yusuff S., Shim J.S., Ferrante A.A., Liu J.O., Parsons M.J.. Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation[J]. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(48), 19264-19269.
Authors:  Rovira M.;  Huang W.;  Yusuff S.;  Shim J.S.;  Ferrante A.A.; et al.
Favorite | TC[WOS]:75 TC[Scopus]:79 | Submit date：2019/01/15
Development  Embryogenesis  Notch-signaling  Progenitor  
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment Journal article
Platz E.A., Yegnasubramanian S., Liu J.O., Chong C.R., Shim J.S., Kenfield S.A., Stampfer M.J., Willett W.C., Giovannucci E., Nelson W.G.. A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment[J]. Cancer Discovery, 2011, 1(1), 68-77.
Authors:  Platz E.A.;  Yegnasubramanian S.;  Liu J.O.;  Chong C.R.;  Shim J.S.; et al.
Favorite | TC[WOS]:136 TC[Scopus]:153 | Submit date：2019/01/15
Effect of nitroxoline on angiogenesis and growth of human bladder cancer Journal article
Shim J.S., Matsui Y., Bhat S., Nacev B.A., Xu J., Bhang H.-E.C., Dhara S., Han K.C., Chong C.R., Pomper M.G., So A., Liu J.O.. Effect of nitroxoline on angiogenesis and growth of human bladder cancer[J]. Journal of the National Cancer Institute, 2010, 102(24), 1855-1873.
Authors:  Shim J.S.;  Matsui Y.;  Bhat S.;  Nacev B.A.;  Xu J.; et al.
Favorite | TC[WOS]:90 TC[Scopus]:94 | Submit date：2019/01/15